Assessing the benefits of prescribed exercise in clinical populations

Not Applicable

• Conditions: Parkinson's disease; Chronic kidney disease; Stroke; Fibromyalgia; Immune system disorders; Cardiovascular disease; osteoarthritis; Post treatment colorectal cancer; Post treatment breast cancer; Chronic obstructive pulmonary disease

• Registration Number: ACTRN12613000389707
• Lead Sponsor: niversity of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Participants must be ambulatory and physician-approved to exercise.
The following diagnoses will be included:
Chronic kidney disease, cardiovascular disease, chronic obstructive pulmonary disease, stroke, Parkinson's disease, osteoarthritis, fibromyalgia, immune and blood diseases, post-breast and -colorectal cancer treatment.

Exclusion Criteria

Inability to exercise; unstable cardiovascular or pulmonary condition.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pre- post-intervention change in estimated VO2 maximum fromsubmaximal Astrand Ryhming cycle ergometer test[After 26 weeks of intervention];SF36v2.0 health questionnaire[After 26 weeks of intervention]

Secondary Outcome Measures

Name	Time	Method
Sitting blood pressure using mercury sphygmomanometer[After 26 weeks of intervention];Sitting resting heart rate using heart rate monitor[After 26 weeks of intervention];Body mass assessed on digital scales[After 26 weeks of intervention];BMI and waist circumference[After 26 weeks of intervention]